TKO President Mark Shapiro and TKO CEO Ariel Emanuel explain why the sports and entertainment company's UFC deal with Paramount includes simulcasts on CBS.

A panel of BBB National Programs' National Advertising Review Board (NARB), the appellate advertising body of BBB National Programs, has recommended that T-Mobile US, Inc. discontinue the express savings claims. A panel of BBB National Programs' National Advertising Review Board (NARB), the appellate advertising body of BBB National Programs, has recommended that T-Mobile US, Inc. discontinue the express savings claims.

LOS ANGELES , Aug. 11, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Biohaven Ltd.

The state-of-the-art safety facility accelerates emergency response and coordination for employees and first responders DOVER, Del. , Aug. 11, 2025 /PRNewswire/ -- Chesapeake Utilities Corporation (NYSE: CPK) proudly marked the five-year anniversary of its Safety Town training facility today with a celebratory event that brought together employees, first responders, government officials and community partners.

LOS ANGELES, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 23, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Flywire Corporation (“Flywire” or the “Company”) (NASDAQ: FLYW) securities between February 28, 2024 and February 25, 2025, inclusive (the “Class Period”).

LOS ANGELES, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 5, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired iRobot Corporation (“iRobot” or the “Company”) (NASDAQ: IRBT) securities between January 29, 2024 and March 11, 2025, inclusive (the “Class Period”).

BENSALEM, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

SAN FRANCISCO--(BUSINESS WIRE)--Laurel, a pioneer in AI-powered time intelligence, today announced a strategic investment from Workday Ventures. The investment affirms Laurel's position as a leading platform transforming how professional services firms capture and leverage time data to drive business value. As part of the Workday Ventures' investment, Laurel will become a Workday Innovation Partner, joining a community of innovators delivering AI capabilities to customers. Laurel's mission is t.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming September 30, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO) securities between May 7, 2025, to July 28, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR NOVO NORDISK INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS.

The RealReal delivered a strong Q2 beat-and-raise, demonstrating durable GMV and active buyer growth, prompting my upgrade to a "Buy" rating. The company's successful shift to a high-margin, consignment-only marketplace model and focus on luxury goods provide a compelling long-term growth thesis. Disciplined cost controls and automation are driving significant margin expansion, meeting my key criteria for a bullish stance.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

Uber's strong execution, scale, and brand power drive robust growth across Mobility, Delivery, and Freight, supported by expanding user base and subscription offerings. Strategic partnerships in autonomous vehicles position Uber to benefit from industry disruption, despite risks from emerging AV competitors and potential platform disintermediation. Financials are impressive: double-digit revenue and profit growth, rising free cash flow, operating leverage, and a substantial share repurchase program enhance shareholder value.

AMC Entertainment Holdings (NYSE:AMC) reported strong second quarter 2025 results, with revenues surging 35% year-over-year, driven by a rebound in movie attendance and increases in per-guest spending. Revenue was $1.4 billion, exceeding analyst estimates by $50 to $60 million.

Empresa Distribuidora y Comercializadora Norte Sociedad Anónima (NYSE:EDN ) Q2 2025 Earnings Conference Call August 11, 2025 10:00 AM ET Company Participants German Ranftl Moreno - Finance and Control Director Lucila Ramallo - Corporate Participant Lucila Ramallo Good morning. My name is Lucila Ramallo, Investor Relations Deputy Manager at Edenor.

Key Inflation Data in Focus.

SCHW's steep 70% reduction in costly funding balances boosts NIR, with 2025 growth projected amid higher rates and lending gains.

Strauss Zelnick,Take-Two Interactive Chairman & CEO, joins 'Money Movers' to discuss Q2 earnings results, the state of the consumer and the upcoming launch of the long-awaited Grand Theft Auto 6.

NEW YORK--(BUSINESS WIRE)---- $PEPG #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG) and reminds investors of the August 11, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has rec.

I was right with my Strong Sell rating for Novo Nordisk A/S and the main pillar of my bear case: market share erosion in weight loss treatment. FY 2025 guidance cuts—sales 8–14% CER and operating profit 10–16%—are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Furthermore, Wegovy is lagging behind tirzepatide in market share. Given revised guidance and flat growth expectations, I expect the stock to consolidate around $50 for the back half of the year. Therefore, my Hold rating.

After months of pushing the U.S. government to reverse restrictions on certain chip sales to China, it seems that Nvidia Corp. and Advanced Micro Devices Inc. will be able to sell there again — but newly reported details on the arrangement have some analysts worried that a dangerous precedent has been set.